A

Atara Biotherapeutics

ATRA

10.290
USD
0.32
(3.21%)
Market Closed
Volume
976
EPS
0
Div Yield
0
P/E
-0
Market Cap
51,803,154
Related Instruments
C
CRSP
-2.450
(-4.28%)
54.840 USD
E
EDIT
-0.28500
(-5.26%)
5.13500 USD
F
FATE
-0.46000
(-8.61%)
4.88000 USD
G
GH
-1.770
(-5.04%)
33.380 USD
I
IOVA
-0.58000
(-6.64%)
8.16000 USD
M
MRTX
0
(0%)
0.000000 USD
N
NBIX
11.660
(8.25%)
153.020 USD
N
NVTA
0
(0%)
0.000000 USD
News

Title: Atara Biotherapeutics Inc.

Sector: Healthcare
Industry: Biotechnology
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).